Bicycle Therapeutics BCYC Cash Flow Statement (2018-2026)

NASDAQ BCYC
$4.30 +0.06 (+1.42%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Bicycle Therapeutics Quarterly Cash Flow Statement

Periods 34 quarters
Latest Jun 2026

Bicycle Therapeutics reported cash from operations of -$49.61M and free cash flow of -$49.87M for the quarter ended Jun 2026, up 31.8% year over year. This cash flow statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-14.68M-19.06M-27.56M-26.83M-28.35M-36.99M-39.06M-42.60M-49.93M-49.57M-26.51M-39.81M-50.80M-57.65M-60.74M-78.95M-59.10M28.05M-60.85M-50.34M
Share-based Compensation
4.72M4.76M10.20M5.67M5.78M5.54M9.04M8.19M7.43M7.81M9.28M9.26M9.20M10.33M10.23M10.27M10.19M11.65M10.88M10.75M
Deferred Taxes
-0.75M-0.87M-1.02M-2.34M-2.11M-1.58M7.27M-0.28M-0.77M-0.11M-3.31M-1.03M-1.32M-0.33M-0.05M0.39M-0.24M0.33M
Gains from Investment Securities
Cash from Operations
21.72M-10.44M-26.40M-23.53M-5.87M-30.31M-46.41M34.10M-1.02M-47.29M-70.87M-44.63M-39.83M-9.40M-86.37M-72.79M-71.17M-19.35M-65.92M-49.61M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization
0.34M0.41M0.42M0.62M1.26M1.39M1.56M1.65M1.69M1.65M1.66M1.64M2.17M1.70M1.63M1.70M1.76M1.34M1.13M1.07M
Change in Working Capital
Change in Receivables
1.00M-0.99M10.34M-9.69M1.99M-2.52M-49.84M49.88M0.13M
Change in Account Payables
-1.96M0.93M-0.26M1.60M3.59M-2.37M-2.00M2.02M3.81M4.17M-5.92M-0.43M-1.24M10.69M-5.02M6.10M-5.07M-2.88M-3.84M-0.06M
Change in Accured Expenses
0.08M1.71M-2.34M5.55M2.29M6.87M-3.13M11.55M-2.33M-3.69M-5.41M1.79M9.58M3.75M-8.21M9.18M1.12M2.00M-2.35M-0.60M
Other Working Capital Changes
26.18M8.64M-3.85M6.27M-0.28M-4.27M-4.90M-10.55M89.69M-5.29M-19.55M-9.12M-2.60M-0.68M-9.73M-2.73M-9.40M-47.34M-1.28M-0.71M
Investing Activities
Capital Expenditures
0.17M1.07M4.76M9.80M2.98M1.45M2.10M0.28M0.50M0.05M0.01M0.42M0.43M0.37M0.60M0.50M0.67M0.57M0.71M0.27M
Cash from Investing Activities
-0.17M-1.07M-4.76M-9.80M-2.98M-1.45M-2.10M-0.28M-0.50M-0.05M-0.01M-0.42M-0.43M-0.37M-0.60M-0.50M-0.67M-0.57M-0.71M-0.27M
Financing Activities
Other financing activities
3.05M2.27M0.45M0.20M0.16M0.18M0.00M0.17M0.14M0.38M1.87M4.50M0.91M0.24M0.00M0.00M0.00M0.03M0.01M0.00M
Debt Issuance and Repayment
Long-Term Debt Issuances
Change in Capital Stock
Net Shares Issued and Repurchased
1.68M0.90M1.55M1.43M2.10M1.86M2.44M1.54M1.92M1.33M
Net Equity Issued and Repurchased
29.84M188.39M2.72M12.10M19.40M0.01M-0.98M
Misc.
Cash from Financing Activities
40.45M190.66M0.45M0.20M0.16M5.89M2.72M12.29M234.63M0.39M1.87M549.61M-31.93M0.20M-0.04M-0.04M-0.03M-0.01M-0.05M-0.05M
Exchange Rate Effect
-1.21M-0.01M-0.60M-1.47M-2.60M3.55M0.45M0.51M-0.90M1.29M-0.42M-0.19M1.70M-1.78M0.47M1.81M-1.25M-0.22M-1.94M-0.05M
Change in Cash
60.79M179.16M-31.31M-34.60M-11.30M-22.32M-45.34M46.62M232.20M-45.66M-69.43M504.37M-70.50M-11.34M-86.55M-71.52M-73.13M-20.16M-68.64M-49.97M
Free Cash Flow
21.55M-11.50M-31.16M-33.33M-8.86M-31.76M-48.51M33.82M-1.53M-47.34M-70.88M-45.05M-40.27M-9.76M-86.97M-73.28M-71.85M-19.92M-66.64M-49.87M
Net Cash Flow
62.00M179.16M-30.71M-33.13M-8.70M-25.87M-45.79M46.11M233.10M-46.95M-69.01M504.56M-72.20M-9.56M-87.02M-73.33M-71.88M-19.93M-66.69M-49.92M